scholarly article | Q13442814 |
P356 | DOI | 10.1056/NEJMC082346 |
P698 | PubMed publication ID | 19228630 |
P2093 | author name string | Giampietro Gasparini | |
Antonio Marchetti | |||
P433 | issue | 8 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | colorectal cancer | Q188874 |
cetuximab | Q420296 | ||
P304 | page(s) | 833-4; author reply 835-6 | |
P577 | publication date | 2009-02-01 | |
P1433 | published in | The New England Journal of Medicine | Q582728 |
P1476 | title | K-ras mutations and cetuximab in colorectal cancer. | |
P478 | volume | 360 |
Q37396252 | A multicenter blinded study to evaluate KRAS mutation testing methodologies in the clinical setting |
Q27851527 | Clinical implications of KRAS mutations in lung cancer patients treated with tyrosine kinase inhibitors: an important role for mutations in minor clones |
Q37916396 | Cytology-based gene mutation tests to predict response to anti-epidermal growth factor receptor therapy: a review |
Q54415409 | Detection of KRAS mutations in colorectal carcinoma patients with an integrated PCR/sequencing and real-time PCR approach. |
Q34565052 | Detection of low-abundance KRAS mutations in colorectal cancer using microfluidic capillary electrophoresis-based restriction fragment length polymorphism method with optimized assay conditions |
Q39416581 | Differences in the frequencies of K-ras c12-13 genotypes by gender and pathologic phenotypes in colorectal tumors measured using the allele discrimination method |
Q21142734 | Multi-determinants analysis of molecular alterations for predicting clinical benefit to EGFR-targeted monoclonal antibodies in colorectal cancer |
Q35986751 | Predictive Molecular Tumour Testing: What Are the Obstacles between Bench and Bedside? |
Q39606707 | Rapid detection of low-abundance K-ras mutation in stools of colorectal cancer patients using chip-based temperature gradient capillary electrophoresis |
Q55689709 | Reply: KRAS status analysis and anti-EGFR therapies: is comprehensiveness a biologist's fancy or a clinical necessity? |
Q37015715 | The status of targeted agents in the setting of neoadjuvant radiation therapy in locally advanced rectal cancers |
Search more.